SuperworthXtant Medical shares outstanding XTNT
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 140.3M
- On a year earlier
- −5.6%
- fewer shares
Xtant Medical had 140.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 5.6% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 150.4M | +8% |
| FY2024 | 139M | +7% |
| FY2023 | 130.1M | +20% |
| FY2022 | 108.5M | +25% |
| FY2021 | 87M | +18% |
| FY2020 | 74M | +463% |
| FY2019 | 13.2M | +0% |
| FY2018 | 13.2M | +769% |
| FY2017 | 1.5M | +26% |
| FY2016 | 1.2M | +22% |
| FY2015 | 990.8K | +78% |
| FY2014 | 556.2K | +33% |
| FY2013 | 418.8K | +18% |
| FY2012 | 356.3K | +5% |
| FY2011 | 338.5K | +11% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 140.3M | −6% | |
| Q1 FY26 | 140.1M | −2% | |
| Q4 FY25 | 150.4M | +8% | |
| Q3 FY25 | 150.4M | +11% | |
| Q2 FY25 | 148.6M | +14% | |
| Q1 FY25 | 143.3M | +10% | |
| Q4 FY24 | 139M | +7% | |
| Q3 FY24 | 135.1M | −0% | |
| Q2 FY24 | 130.3M | +20% | |
| Q1 FY24 | 130.2M | +20% | |
| Q4 FY23 | 130.1M | +20% | |
| Q3 FY23 | 135.7M | +45% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Xtant Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.